Krzysztof Kucia Selected Research

Paranoid Schizophrenia (Delusional Disorder)

1/2018	Polymorphic Variants of TNFR2 Gene in Schizophrenia and Its Interaction with -308G/A TNF-α Gene Polymorphism.
1/2017	Association Study of Tumor Necrosis Factor Receptor 1 (TNFR1) Gene Polymorphisms with Schizophrenia in the Polish Population.
3/2014	Heat shock protein 70 gene polymorphisms are associated with paranoid schizophrenia in the Polish population.
1/2013	BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population.
1/2013	Association of interleukin 2 (IL-2), interleukin 6 (IL-6), and TNF-alpha (TNFα) gene polymorphisms with paranoid schizophrenia in a Polish population.
8/2012	Association study of interleukin-4 polymorphisms with paranoid schizophrenia in the Polish population: a critical approach.
3/2011	Association study of interferon gamma (IFN-γ) +874T/A gene polymorphism in patients with paranoid schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Krzysztof Kucia Research Topics

Disease

10	Schizophrenia (Dementia Praecox) 01/2022 - 03/2011
7	Paranoid Schizophrenia (Delusional Disorder) 01/2018 - 03/2011
2	Major Depressive Disorder (Major Depressive Disorders) 05/2011 - 03/2011
1	Mood Disorders (Mood Disorder) 01/2020
1	Treatment-Resistant Depressive Disorder 01/2019
1	Chronic Renal Insufficiency 09/2017
1	Intellectual Disability (Idiocy) 09/2017
1	Mental Disorders (Mental Disorder) 09/2017
1	Endometrial Neoplasms (Endometrial Cancer) 09/2016
1	Venous Thromboembolism 09/2016
1	Psychotic Disorders (Schizoaffective Disorder) 09/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2011
1	Liver Diseases (Liver Disease) 01/2007

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2018 - 03/2011
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 03/2011
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	NucleotidesIBA 01/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	Excitatory Amino Acid Transporter 2IBA 01/2019
1	Glycine Plasma Membrane Transport ProteinsIBA 01/2019
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2018
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2017
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 09/2016
1	Estrogens (Estrogen)FDA Link 09/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 09/2016
1	Selective Estrogen Receptor Modulators (SERM)IBA 09/2016
1	Raloxifene Hydrochloride (Evista)FDA Link 09/2016
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 03/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013
1	Interleukin-2 (IL2)IBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 01/2013
1	Interleukin-4 (Interleukin 4)IBA 08/2012
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2011
1	Interferon-gamma (Interferon, gamma)IBA 03/2011
1	Antidepressive Agents (Antidepressants)IBA 01/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2019
1	Therapeutics 01/2019
1	Vagus Nerve Stimulation 01/2019
1	Renal Dialysis (Hemodialysis) 09/2017
1	Polypharmacy 09/2017